Women’s health

Autism spectrum disorders, Medical News, Neurodevelopmental disorders, Pediatrics, Pharmaceuticals, Women's health
No association found between epidural analgesia during labor and risk of autism spectrum disorders

The researchers found that after assessing 388,254 children and mothers included in the cohort, no relationship between epidural use and autism spectrum disorders (ASD) was found. According to a recently

Diet, Medical News, Men's health, Neuroscience, Pediatrics, Women's health, World health
Significant association found between e-cigarette use and eating disorders in young adult populations

The study found that there were statistically significant differences between the vaping and non-vaping groups for all categories, including for participants who were at an elevated risk for an eating

Cancer, Diet, Exercise, Medical News, Metabolic syndrome, Obesity, Pediatrics, Women's health, World health
Maternal obesity linked to increased risk of colorectal cancer in offspring

The research team found that adult offspring whose mothers were obese during pregnancy faced a 100% greater risk of developing colorectal cancer than those whose mothers were not. A recently

Medical News, Neuroscience, Pharmaceuticals, Women's health
FDA approves first dual-treatment migraine medication, ‘paradigm shift’ in migraine management

According to the company, taking the medication every other day for a week decreased migraine days by 30%, and nearly half of the participants reported a 50% reduction in moderate-to-severe

Featured, Sleep, Women's health, World health
New position statement emphasizes sleep is essential to health, should have a ‘prominent place’ in K-12 education

The statement highlights the significance of sleep for the health and well-being of children, adolescents, and adults. According to the statement, sleep education should be emphasized in K-12 and college

Biotechnology, Cancer, Medical News, Pharmaceuticals, Women's health
Promising ovarian cancer treatment proves effective and efficient

Preclinical trials of a new radiopharmaceutical for the treatment of ovarian cancer have shown promising results, with tumor growth and mass significantly reduced after use. The new radiopharmaceutical, which is